These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32898553)

  • 21. The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway.
    Lee YD; Kim B; Jung S; Kim H; Kim MK; Kwon JO; Song MK; Lee ZH; Kim HH
    Exp Mol Med; 2020 Mar; 52(3):514-528. PubMed ID: 32210358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.
    Tao T; Sun J; Peng Y; Wang P; Chen X; Zhao W; Li Y; Wei L; Wang W; Zheng Y; Wang Y; Zhang X; Zhu MS
    J Genet Genomics; 2019 Feb; 46(2):87-96. PubMed ID: 30850274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.
    Ito Y; Teitelbaum SL; Zou W; Zheng Y; Johnson JF; Chappel J; Ross FP; Zhao H
    J Clin Invest; 2010 Jun; 120(6):1981-93. PubMed ID: 20501942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption.
    Jang JS; Kang IS; Cha YN; Lee ZH; Dinauer MC; Kim YJ; Kim C
    BMB Rep; 2019 Nov; 52(11):659-664. PubMed ID: 31072447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts.
    Kawamata A; Inoue A; Miyajima D; Hemmi H; Mashima R; Hayata T; Ezura Y; Amagasa T; Yamanashi Y; Noda M
    J Cell Physiol; 2011 Dec; 226(12):3087-93. PubMed ID: 21732353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation of Rho family proteins Rac1 and Cdc42 in cartilage development and calcified tissue formation.
    Ikehata M; Yamada A; Fujita K; Yoshida Y; Kato T; Sakashita A; Ogata H; Iijima T; Kuroda M; Chikazu D; Kamijo R
    Biochem Biophys Res Commun; 2018 Jun; 500(3):525-529. PubMed ID: 29626467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cytoplasmic Dynein Associated Protein NDE1 Regulates Osteoclastogenesis by Modulating M-CSF and RANKL Signaling Pathways.
    Das BK; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of osteoclast differentiation and bone resorption by Rho GTPases.
    Touaitahuata H; Blangy A; Vives V
    Small GTPases; 2014; 5():e28119. PubMed ID: 24614674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
    Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
    Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
    Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
    J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
    Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
    J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1.
    Yan J; Chen S; Zhang Y; Li X; Li Y; Wu X; Yuan J; Robling AG; Kapur R; Chan RJ; Yang FC
    Hum Mol Genet; 2008 Apr; 17(7):936-48. PubMed ID: 18089636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas/S1P
    Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid Lineage Ablation of
    Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
    Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
    J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST5 Positively Regulates Osteoclastogenesis via Src/Syk/calcium Signaling Pathways.
    Kim MK; Kim B; Kwon JO; Song MK; Jung S; Lee ZH; Kim HH
    Mol Cells; 2019 Nov; 42(11):810-819. PubMed ID: 31707778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.
    Liu Y; Dou Y; Yan L; Yang X; He B; Kong L; Smith W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.